Literature DB >> 20864680

Dual roles of CD40 on microbial containment and the development of immunopathology in response to persistent fungal infection in the lung.

Gwo-Hsiao Chen1, John J Osterholzer, Mun Y Choe, Roderick A McDonald, Michal A Olszewski, Gary B Huffnagle, Galen B Toews.   

Abstract

Persistent pulmonary infection with Cryptococcus neoformans in C57BL/6 mice results in chronic inflammation that is characterized by an injurious Th2 immune response. In this study, we performed a comparative analysis of cryptococcal infection in wild-type versus CD40-deficient mice (in a C57BL/6 genetic background) to define two important roles of CD40 in the modulation of fungal clearance as well as Th2-mediated immunopathology. First, CD40 promoted microanatomic containment of the organism within the lung tissue. This protective effect was associated with: i) a late reduction in fungal burden within the lung; ii) a late accumulation of lung leukocytes, including macrophages, CD4+ T cells, and CD8+ T cells; iii) both early and late production of tumor necrosis factor-α and interferon-γ by lung leukocytes; and iv) early IFN-γ production at the site of T cell priming in the regional lymph nodes. In the absence of CD40, systemic cryptococcal dissemination was increased, and mice died of central nervous system infection. Second, CD40 promoted pathological changes in the airways, including intraluminal mucus production and subepithelial collagen deposition, but did not alter eosinophil recruitment or the alternative activation of lung macrophages. Collectively, these results demonstrate that CD40 helps limit progressive cryptococcal growth in the lung and protects against lethal central nervous system dissemination. CD40 also promotes some, but not all, elements of Th2-mediated immunopathology in response to persistent fungal infection in the lung.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20864680      PMCID: PMC2966803          DOI: 10.2353/ajpath.2010.100141

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  71 in total

Review 1.  Animal models of asthma.

Authors:  Jason H T Bates; Mercedes Rincon; Charles G Irvin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-06-26       Impact factor: 5.464

2.  Involvement of endogenously synthesized interleukin (IL)-18 in the protective effects of IL-12 against pulmonary infection with Cryptococcus neoformans in mice.

Authors:  K Kawakami; M H Qureshi; T Zhang; Y Koguchi; S Yara; K Takeda; S Akira; M Kurimoto; A Saito
Journal:  FEMS Immunol Med Microbiol       Date:  2000-03

3.  Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection.

Authors:  L Soong; J C Xu; I S Grewal; P Kima; J Sun; B J Longley; N H Ruddle; D McMahon-Pratt; R A Flavell
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

4.  Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications.

Authors:  S C Lee; D W Dickson; A Casadevall
Journal:  Hum Pathol       Date:  1996-08       Impact factor: 3.466

5.  IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice.

Authors:  K A Hoag; M F Lipscomb; A A Izzo; N E Street
Journal:  Am J Respir Cell Mol Biol       Date:  1997-12       Impact factor: 6.914

6.  Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.

Authors:  R T Gazzinelli; S Hieny; T A Wynn; S Wolf; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung.

Authors:  John J Osterholzer; Rishi Surana; Jami E Milam; Gerald T Montano; Gwo-Hsiao Chen; Joanne Sonstein; Jeffrey L Curtis; Gary B Huffnagle; Galen B Toews; Michal A Olszewski
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

8.  CD40 is required for the optimal induction of protective immunity to Mycobacterium avium.

Authors:  Manuela Flórido; Ana Sofia Gonçalves; M Salomé Gomes; Rui Appelberg
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

9.  Disruption of CD40/CD40L interaction influences the course of Cryptococcus neoformans infection.

Authors:  Donatella Pietrella; Patrizia Lupo; Stefano Perito; Paolo Mosci; Francesco Bistoni; Anna Vecchiarelli
Journal:  FEMS Immunol Med Microbiol       Date:  2004-01-15

10.  CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.

Authors:  P Borrow; A Tishon; S Lee; J Xu; I S Grewal; M B Oldstone; R A Flavell
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  9 in total

1.  Epigallocatechin-3-Gallate Inhibition of Myeloperoxidase and Its Counter-Regulation by Dietary Iron and Lipocalin 2 in Murine Model of Gut Inflammation.

Authors:  Beng San Yeoh; Rodrigo Aguilera Olvera; Vishal Singh; Xia Xiao; Mary J Kennett; Bina Joe; Joshua D Lambert; Matam Vijay-Kumar
Journal:  Am J Pathol       Date:  2016-03-08       Impact factor: 4.307

2.  Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production.

Authors:  Benjamin J Murdock; Gary B Huffnagle; Michal A Olszewski; John J Osterholzer
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

3.  Early or late IL-10 blockade enhances Th1 and Th17 effector responses and promotes fungal clearance in mice with cryptococcal lung infection.

Authors:  Benjamin J Murdock; Seagal Teitz-Tennenbaum; Gwo-Hsiao Chen; Anthony J Dils; Antoni N Malachowski; Jeffrey L Curtis; Michal A Olszewski; John J Osterholzer
Journal:  J Immunol       Date:  2014-09-15       Impact factor: 5.422

4.  Induction of IL-12 production in human peripheral monocytes by Trypanosoma cruzi Is mediated by glycosylphosphatidylinositol-anchored mucin-like glycoproteins and potentiated by IFN- γ and CD40-CD40L interactions.

Authors:  Lúcia Cristina Jamli Abel; Ludmila Rodrigues Pinto Ferreira; Isabela Cunha Navarro; Monique Andrade Baron; Jorge Kalil; Ricardo Tostes Gazzinelli; Luiz Vicente Rizzo; Edecio Cunha-Neto
Journal:  Mediators Inflamm       Date:  2014-07-09       Impact factor: 4.711

5.  Disruption of Early Tumor Necrosis Factor Alpha Signaling Prevents Classical Activation of Dendritic Cells in Lung-Associated Lymph Nodes and Development of Protective Immunity against Cryptococcal Infection.

Authors:  Jintao Xu; Alison J Eastman; Adam Flaczyk; Lori M Neal; Guolei Zhao; Jacob Carolan; Antoni N Malachowski; Valerie R Stolberg; Mohammed Yosri; Stephen W Chensue; Jeffrey L Curtis; John J Osterholzer; Michal A Olszewski
Journal:  MBio       Date:  2016-07-12       Impact factor: 7.867

Review 6.  Immunoregulation in Fungal Diseases.

Authors:  Jonathan A Roussey; Michal A Olszewski; John J Osterholzer
Journal:  Microorganisms       Date:  2016-12-10

7.  Epigenetic stabilization of DC and DC precursor classical activation by TNFα contributes to protective T cell polarization.

Authors:  Alison J Eastman; Jintao Xu; Jennifer Bermik; Nicole Potchen; Aaron den Dekker; Lori M Neal; Guolei Zhao; Antoni Malachowski; Matt Schaller; Steven Kunkel; John J Osterholzer; Ilona Kryczek; Michal A Olszewski
Journal:  Sci Adv       Date:  2019-12-04       Impact factor: 14.136

Review 8.  T cell responses to control fungal infection in an immunological memory lens.

Authors:  Jaishree Sharma; Srinivasu Mudalagiriyappa; Som Gowda Nanjappa
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

9.  Cryptococcus neoformans Infection in Mice Lacking Type I Interferon Signaling Leads to Increased Fungal Clearance and IL-4-Dependent Mucin Production in the Lungs.

Authors:  Ko Sato; Hideki Yamamoto; Toshiki Nomura; Ikumi Matsumoto; Tomomitsu Miyasaka; Tong Zong; Emi Kanno; Kazuko Uno; Keiko Ishii; Kazuyoshi Kawakami
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.